On June 23, 2026, the U.S. Department of Justice (DOJ) and Department of Health and Human Services (HHS) announced the results of the 2026 National Health Care Fraud Takedown, charging 455 defendants in alleged schemes involving more than $6.5 billion in false claims. The announcement is notable not only for its size, but for what it says about the maturation of health care fraud enforcement. DOJ has been talking about data analytics and whole-of-government coordination for years. This year’s Takedown suggests those concepts are no longer just aspirational talking points – they are increasingly the operating model, with data used earlier and more aggressively, familiar priorities like opioids joined by fast-emerging targets like allografts and skin grafts, and DOJ’s new National Fraud Enforcement Division (NFED) positioned as a coordinating hub.
The Numbers: Smaller Than 2025, Still Historically Significant
The 2026 Takedown did not match last year’s record-setting total, which was driven in large part by the $10 billion-plus “Operation Gold Rush” medical supply fraud. Even so, the numbers remain significant: 455 defendants, including 90 doctors and other licensed medical professionals; alleged schemes involving more than $6.5 billion in false claims; and more than $182 million in seized assets. DOJ also emphasized tools beyond criminal charges, including Centers for Medicare & Medicaid Services (CMS) suspensions and revocations, HHS Office of Inspector General (OIG)...
Acting Cebu City Prosecutor Jo-ana Marie Desuyo charged Cebu-based businessman Mark Y. Yu with perjury under Article 183 of the Revised Penal Code over false statements in an affidavit accusing t...